• 1

    Plachouri KM, Georgiou S: Therapeutic approaches to pyogenic granuloma: an updated review. Int J Dermatol 58: 642, 2019.

  • 2

    Piraccini BM, Bellavista S, Misciali C, et al.: Periungual and subungual pyogenic granuloma. Br J Dermatol 163: 941, 2010.

  • 3

    Gupta D, Singh N, Thappa DM: Is timolol an effective treatment for pyogenic granuloma? Int J Dermatol 55: 592, 2016.

  • 4

    Mashiah J, Hadj-Rabia S, Slodownik D, et al.: Effectiveness of topical propranolol 4% gel in the treatment of pyogenic granuloma in children. J Dermatol 46: 245, 2019.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Wine Lee L, Goff KL, Lam JM, et al.: Treatment of pediatric pyogenic granulomas using beta-adrenergic receptor antagonists. Pediatr Dermatol 31: 203, 2014.

  • 6

    Piraccini BM, Alessandrini A, Dika E, et al.: Topical propranolol 1% cream for pyogenic granulomas of the nail: open-label study in 10 patients. J Eur Acad Dermatol Venereol 30: 901, 2016.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Khorsand K, Maier M, Brandling-Bennett HA: Pyogenic granuloma in a 5-month-old treated with topical timolol. Pediatr Dermatol 32: 150, 2015.

  • 8

    Knopfel N, Escudero-Gongora MDM, Bauza A, et al.: Timolol for the treatment of pyogenic granuloma (PG) in children. J Am Acad Dermatol 75: e105, 2016.

  • 9

    Provvidenziale L, Russo F, Taddeucci P, et al.: Treatment of childhood pyogenic granuloma of the nail bed with topical timolol. Dermatol Ther 33: e13710, 2020.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10

    Malik M, Murphy R: A pyogenic granuloma treated with topical timolol. Br J Dermatol 171: 1537, 2014.

  • 11

    Chisholm KM, Chang KW, Truong MT, et al.: Beta-adrenergic receptor expression in vascular tumors. Mod Pathol 25: 1446, 2012.

  • 12

    Berk DR, Lehman PA, Franz TJ, et al.: On topical timolol gel-forming solution for infantile hemangiomas. Pediatr Dermatol 30: 160, 2013.

  • 13

    Porter ME, Teisberg EO: Redefining Health Care: Creating Value-Based Competition on Results, Harvard Business School Press, Boston, 2006.

Treatment of a Large Nail-Bed Pyogenic Granuloma with Topical Timolol

Sarah A. Frommer Texas Children’s Hospital, Austin, TX.

Search for other papers by Sarah A. Frommer in
Current site
Google Scholar
PubMed
Close
 MD, PhD
and
Kaylee O. Leathers Dell Medical School at the University of Texas at Austin, Austin, TX.

Search for other papers by Kaylee O. Leathers in
Current site
Google Scholar
PubMed
Close
 MD

Nail pyogenic granulomas are common benign vascular lesions often occurring after trauma. A variety of treatment modalities exist, including topical therapies and surgical excision, although both have their pros and cons. In this communication, we describe the case of a 7-year-old boy with repeated toe trauma, who developed a large nail bed pyogenic granuloma after undergoing surgical debridement and nail bed repair. He was treated with 3 months of topical 0.5% timolol maleate, resulting in complete resolution of the pyogenic granuloma and minimal nail deformity.

Corresponding author: Sarah A. Frommer, MD, PhD, Texas Children’s Hospital, 8611 N Mopac Expy, Ste 300, Austin, TX 78759. (E-mail: dr.sarah.frommer@gmail.com)
Save